Rhee, Chin Kookvan Boven, Job F MYau Ming, Simon WanPark, Hye YunKim, Deog KyeomPark, Hae-SimZhi Jie, Joanna LingYoo, Kwang-HaPrice, David B2019-10-042019-10-042019-03-31Rhee, C K, van Boven, J F M, Yau Ming, S W, Park, H Y, Kim, D K, Park, H-S, Zhi Jie, J L, Yoo, K-H & Price, D B 2019, 'Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation', The journal of allergy and clinical immunology. In practice, vol. 7, no. 3, pp. 934-942. https://doi.org/10.1016/j.jaip.2018.09.0272213-2198Mendeley: fea1fb15-02e6-3fae-b3af-c23622641695http://hdl.handle.net/2164/13065This study was funded by Mundipharma Korea Limited (Seoul, Korea).91627747engasthmainhalerdry powder inhalerpressurized metered-dose inhalercost-effectivenessDry powder inhalerEconomic evaluationInhalerPressurized metered-dose inhalerCost-effectivenessAsthmaCAREOBSTRUCTIVE PULMONARY-DISEASETHERAPYSELECTIONASSOCIATIONBURDENR MedicineImmunology and AllergyRJournal article10.1016/j.jaip.2018.09.027http://www.scopus.com/inward/record.url?scp=85055862124&partnerID=8YFLogxKhttp://www.mendeley.com/research/changing-inhaler-device-impact-reallife-asthma-outcomes-clinical-economic-evaluation73